Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether aspirin may reduce the risk for CVD, death, and kidney failure outcomes is uncertain
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
BackgroundPeople with chronic kidney disease (CKD) have higher risks of cardiovascular disease compa...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The rel...
In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The rel...
Kidney transplant recipients are at increased risk for adverse safety events related to their reduce...
Kidney transplant recipients are at increased risk for adverse safety events related to their reduce...
Kidney transplant recipients (KTRs) have increased risk for cardiovascular disease (CVD). Our object...
Kidney transplant recipients (KTRs) have increased risk for cardiovascular disease (CVD). Our object...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We ...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Kidney transplant recipients have traditional and nontraditional risk factors which can lead to coro...
Rationale & objectiveCardiovascular disease (CVD) is common and overall graft survival is subopt...
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
BackgroundPeople with chronic kidney disease (CKD) have higher risks of cardiovascular disease compa...
Cardiovascular disease (CVD) is the leading cause of death in kidney transplant recipients. Whether ...
In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The rel...
In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The rel...
Kidney transplant recipients are at increased risk for adverse safety events related to their reduce...
Kidney transplant recipients are at increased risk for adverse safety events related to their reduce...
Kidney transplant recipients (KTRs) have increased risk for cardiovascular disease (CVD). Our object...
Kidney transplant recipients (KTRs) have increased risk for cardiovascular disease (CVD). Our object...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We ...
Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience exce...
Kidney transplant recipients have traditional and nontraditional risk factors which can lead to coro...
Rationale & objectiveCardiovascular disease (CVD) is common and overall graft survival is subopt...
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
Mild hyperphosphatemia is a putative risk factor for cardiovascular disease [CVD], loss of kidney fu...
BackgroundPeople with chronic kidney disease (CKD) have higher risks of cardiovascular disease compa...